Jacques Schmid
Gastroenterology · Commack, NYNPI 1972500858
Payments from drug & device makers
Across 124 payments — averaging $17.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$318
- Johnson & Johnson$315
- Pfizer$310
- AbbVie$198
- AstraZeneca$197
- Lilly USA, LLC$166
- plus $671 from 13 others
What the payments were for
- Food & beverage$2,175100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 20 | $318 |
| Johnson & Johnson(2 entities) | 17 | $315 |
| Pfizer | 17 | $310 |
| AbbVie(2 entities) | 10 | $198 |
| AstraZeneca | 13 | $197 |
| Lilly USA, LLC | 9 | $166 |
| Amarin Pharma, Inc. | 7 | $144 |
| Sanofi Pasteur Inc. | 9 | $136 |
| Merck | 6 | $102 |
| Novo Nordisk | 4 | $73 |
| Exact Sciences | 2 | $39 |
| Paratek Pharmaceuticals, Inc. | 2 | $38 |
| Astellas Pharma US Inc | 1 | $29 |
| Bausch Health US, LLC | 2 | $27 |
| Amgen | 1 | $20 |
| Boehringer Ingelheim | 1 | $18 |
| Althera Pharmaceuticals LLC | 1 | $17 |
| Incyte Corporation | 1 | $16 |
| Seqirus USA Inc | 1 | $11 |
How this compares
$2,175 in reported general payments places this provider in the 50th percentile of 1,682 gastroenterology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 16 | $27,677 |
| EliquisApixaban | 23 | $24,475 |
| Levothyroxine Sodium | 97 | $1,628 |
| Metoprolol Succinate | 68 | $1,318 |
| Ezetimibe | 41 | $1,217 |
| Atorvastatin Calcium | 111 | $894 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $716 |
| SynthroidLevothyroxine Sodium | 17 | $696 |
| Pantoprazole Sodium | 31 | $667 |
| Simvastatin | 59 | $604 |
| Omeprazole | 44 | $529 |
| Potassium Chloride | 12 | $515 |
| Rosuvastatin Calcium | 40 | $436 |
| Hydrochlorothiazide | 47 | $409 |
| Metformin Hcl | 46 | $388 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $18 | $27,67716 claims |
| PfizerEliquis | $310 | $24,47523 claims |
| AbbVieSynthroid | $198 | $69617 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 1,682 gastroenterology providers in New York.
Other gastroenterology in Commack
- Michael GerdisYonkers$11.9M
- David HudesmanNew York$3.6M
- Ellen ScherlNew York$2.9M
- Igor GrosmanBrooklyn$2.8M
- Bruce SandsNew York$2.8M
- Arun SwaminathNew York$2.7M
- Sonal KumarNew York$2.3M
- David Carr LockeNew York$2.1M
- Arthur KornbluthNew York$1.9M
- Maya SrivastavaWilliamsville$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.